Recent advances in the management of tuberculosis

Authors

  • Muhammad Babar Khan Department of Medicine, Combined Military Hospital, Multan
  • Asher Ahmed Mashhood Department of Dermatology, Combined Military Hospital, Multan
  • Shaukat Mehmood Qureishi Department of Preventive Medicine, Combined Military Hospital, Multan

DOI:

https://doi.org/10.66344/jpad.v15i2.635

Keywords:

Tuberculosis, Mycobacterium tuberculosis, sputum microscopy, Mantoux test, antituberculosis drugs.

Abstract

The importance of tuberculosis in Pakistan and other underdeveloped countries cannot be
over emphasized. Despite inclusion of BCG vaccination in the EPI program and availability
of the anti-tuberculosis medicines at affordable prices, tuberculosis is still the number one
cause of prolonged morbidity. The emergence of Human Immunodeficiency Virus and multidrug
resistant tuberculosis has added another dimension to an already complicated situation
of tuberculosis globally. In response, vigorous efforts have been made to stratify the patient
population and streamline the treatment of various categories of tuberculosis patients.

References

Iseman MD. Mycobacterial

diseases of the lungs. In: Hanley

ME, Welsh CH, eds. Current

Diagnosis and Treatment in

Pulmonary Medicine. New York:

McGraw Hill; 2004. p. 399-409.

Guidelines for diagnosis and

management for tuberculosis.Karachi: Pakistan Chest Society;

Treatment of tuberculosis. WHO

guidelines for national

programmes, 3rd edition; 2003.

Aziz A, Aziz K. Tuberculosispresent

and future. Pak J Med Sci

; 14; 73-81.

Shankar PS. Investigations. In:

Shankar PS, ed. Principles and

Management of Tuberculosis.

Philadelphia: Churchill

Livingstone; 2002. p. 109-123.

Ormerod LP. Clinical features and

management of tuberculosis. In:

Gibson GJ, Geddes DM, Costable

U et al., eds. Respiratory Medicine.

New York: WB Saunders; 2003. p.

-63.

Davies PDO, ed. Clinical

Tuberculosis. Philadelphia:

Chapman and Hall; 1998.

Iseman M. Treatment of multidrug

resistant tuberculosis. N Eng J Med

; 328: 784-90.

Horsburgh CR. Priorities for the

treatment of latent tuberculosis

infection in United States. N Eng J

Med 2004; 350: 2060-7.

Aziz A, Siddiqi SH, Aziz K, Ishaq

M. Drug resistance of

Mycobacterium tuberculosis

isolated from treated patients in

Pakistan. Tubercle 1989; 70: 45-51.

Guidelines for diagnosis and

management of tuberculosis.

National tuberculosis control

programme, Ministry of Health,

Govt of Pakistan; 2002.

Aziz A, Ishaq M, Jaffar NA et al.

Clinical trial of 2 short course (6

months) regimens and standard

regimen (12 months) chemotherapy

in re-treatment of pulmonary

tuberculosis in Pakistan. Am Rev

Resp Dis 1986; 134: 1056-61.

Rose AMC, Watson JM, Graham C

et al. Tuberculosis at the turn of the

century. Thorax 2001; 56: 173-9.

Joint tuberculosis committee of the

British Thoracic Society.

Chemotherapy and Management of

Tuberculosis in the United

Kingdom. Recommendations 1998.

Thorax 1998; 83: 153-6.

Downloads

Published

28.12.2016

Issue

Section

Review Articles

How to Cite

1.
Recent advances in the management of tuberculosis. J Pak Assoc Dermatol [Internet]. 2016 Dec. 28 [cited 2026 Aug. 2];15(2):151-60. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/635